Metabolic syndrome does not impair the response to alfuzosin treatment in men with lower urinary tract symptoms a double blind randomized placebo controlled study


ALTIN S., OZAN T., İLHAN S., İLHAN N., ONUR A. R.

Türk Üroloji Dergisi/Turkish Journal of Urology, cilt.41, sa.3, ss.125-131, 2015 (Hakemli Dergi)